Facebook Pixel {العنوان: سلسلة} | {اسم المغناطيس: سلسلة} - {الفئة: سلسلة} - اقرأ هذه القصة على Magzter.com

يحاول ذهب - حر

The bar for successful obesity drugs has been rising sharply

January 02, 2025

|

Mint Bangalore

Nothing else explains why Novo's stock fell after a drug test result

- LISA JARVIS

In a new study, an experimental obesity drug from Novo Nordisk, CagriSema allowed people to lose more than 20% of their body weight, on average, a result that caused the Danish company's stock price to fall by as much as 29%. Yes, fall. For anyone not following the heated race for obesity drug dominance, it may look like we're living upside-down. After all, if this data were unveiled three years ago, the market reaction would have been wildly different. The stock might have gone up and headlines would have heralded an advance in the fight against obesity. But we're in a new era of obesity medicine. The bar for success, once modest, has soared—especially so for CagriSema. Let me explain.

Though Novo will make mind-blowing money from its existing obesity drugs in the coming years (its GLP-1 drugs are likely to become pharma's most lucrative franchise next year), CagriSema was seen as essential for continued growth in 2030 and beyond. And the study suggests it may not be the contender investors had hoped for.

المزيد من القصص من Mint Bangalore

Mint Bangalore

Mint Bangalore

Iran continues attacks amid global energy supply worry

Iran's military plans to start targeting banks and financial institutions in West Asia

time to read

2 mins

March 12, 2026

Mint Bangalore

India must act before the coming AI-pocalypse kicks in

AI enables the state to surveil citizens at a massive scale. This raises serious questions of privacy, freedom and dissidence

time to read

3 mins

March 12, 2026

Mint Bangalore

Porsche pivots to cost-cutting

Porsche AG's new chief executive Michael Leiters plans to cut spending at the German manufacturer and add models positioned above the 911 to bolster profits.

time to read

1 min

March 12, 2026

Mint Bangalore

Mint Bangalore

Trump says the Iran war is nearly won but Israel has other ideas

Israel is sticking with its overarching goal of creating the conditions for regime change in Tehran

time to read

6 mins

March 12, 2026

Mint Bangalore

Wars and their market impact: What the historical record says

The history of conflicts would suggest that shaken stock markets don't take long to regain normalcy

time to read

4 mins

March 12, 2026

Mint Bangalore

Mint Bangalore

Sebi eases PARS compliance norms

A move aimed at easing compliance requirements, the Securities and Exchange Board of India (Sebi) on Wednesday relaxed certification norms for persons associated with research services (PARS), allowing sales staff, relationship managers and other non-research personnel to qualify through a lighter certification module.

time to read

1 min

March 12, 2026

Mint Bangalore

Mint Bangalore

VinFast hires veteran auto execs to scale India EV push

The firm recruited over half a dozen leaders from global automakers such as Hyundai, BMW

time to read

2 mins

March 12, 2026

Mint Bangalore

RBI clears Cred as a payment aggregator

Fintech platform Cred on Wednesday said it has received the final authorization from the Reserve Bank of India (RBI) to operate as a payment aggregator.

time to read

1 min

March 12, 2026

Mint Bangalore

Mint Bangalore

Airlines seek pilot duty time relief as longer routes bite

IndiGo and Air India Group said to have sought the relief following the West Asia conflict

time to read

2 mins

March 12, 2026

Mint Bangalore

Mint Bangalore

The world needs these two Middle East pipelines now more than ever

The world needs these two Middle East pipelines now more than ever

time to read

4 mins

March 12, 2026

Listen

Translate

Share

-
+

Change font size